| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 1.762 | 655 | 578 | 1.081 | 2.124 | 1.199 | 728 | 771 | 1.638 | 2.214 |
| Total Income - EUR | 1.762 | 655 | 578 | 1.081 | 2.124 | 1.199 | 728 | 771 | 1.638 | 2.214 |
| Total Expenses - EUR | 1.899 | 2.691 | 2.272 | 5.610 | 6.077 | 2.465 | 1.658 | 3.749 | 8.135 | 8.756 |
| Gross Profit/Loss - EUR | -137 | -2.036 | -1.694 | -4.529 | -3.952 | -1.266 | -930 | -2.978 | -6.498 | -6.542 |
| Net Profit/Loss - EUR | -189 | -2.053 | -1.712 | -4.540 | -3.974 | -1.289 | -952 | -2.993 | -6.514 | -6.573 |
| Employees | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
Check the financial reports for the company - Mara Sano Therapy Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 19 | 19 | 18 | 18 | 18 | 17 | 17 | 17 | 17 | 17 |
| Current Assets | 91 | 210 | 14 | 141 | 735 | 417 | 194 | 170 | 128 | 90 |
| Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 0 | 0 | 0 | 64 | 712 | 0 | 0 | 0 | 0 | 0 |
| Cash | 91 | 210 | 14 | 77 | 23 | 417 | 194 | 170 | 128 | 90 |
| Shareholders Funds | -1.523 | -3.560 | -5.211 | -9.655 | -13.442 | -14.476 | -15.107 | -18.146 | -24.605 | -31.041 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 1.633 | 3.788 | 5.244 | 9.815 | 14.195 | 14.911 | 15.318 | 18.334 | 24.750 | 31.147 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8690 - 8690" | |||||||||
| CAEN Financial Year |
8690
|
|||||||||
Comments - Mara Sano Therapy Srl